Hero MotoCorp, the two-wheeler manufacturer, said it will invest $60 million in US-based Zero motorcycles to jointly develop electric motor...

In a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurit...

NMDC has terminated a Rs 1,400-cr contract with BHEL for building the raw material handling system.

Dr Butte's aim is drug re-positioning. It is not about getting a new drug out in the market, but finding a new use for an old drug that's a...

The acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.

Japan’s second-largest pharma company, the $10-billion Astellas Pharma, intends to emerge as a niche player in India.

Ranbaxy, the Indian unit of Japanese drugmaker Daiichi Sankyo, was to launch the generic version of the Japan-based Astellas’ Flomax on Mar...

Ranbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...

Ranbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...

Drug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...

Ranbaxy Laboratories has reached an out-of-court settlement with UK’s pharma major GlaxoSmithKline to market generic copies of the latter’s...